SCHEMBL6656924

SCHEMBL6656924

CCC(C)C[PH](C)(CC(C)CC)CC(C)CC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17310158 0.87
SCHEMBL7327498 0.72
SCHEMBL130109 0.72
SCHEMBL20150150 0.71 TSHR (0.30) TSHR
SCHEMBL14489511 0.71
Hydrochloric Acid SCHEMBL10488451 0.69
SCHEMBL7654 0.69
SCHEMBL7755370 0.69 TSHR (0.46) TSHR
SCHEMBL17472833 0.67
SCHEMBL443577 0.67 TSHR (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178077-B1 The preparation of surface modified silica GOODYEAR TIRE & RUBBER (US) 2004-06-16 EP disclosed
US-6465670-B2 SURFACE TREATMENT USING ORGANOSILICON COMPOUND, SOLVENT AND PHASE TRANSFER CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2002-10-15 US disclosed
US-20020022085-A1 Preparation of surface modified silica GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-21 US disclosed
EP-1178077-A1 The preparation of surface modified silica THE GOODYEAR TIRE & RUBBER COMPANY (US) 2002-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020022085-A1 Preparation of surface modified silica OSTC, SAMM50, SSRP1 TSHR 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.